FDA Import Refusal AEK-8613440-7/31/1 — ASTRA ZENECA
The FDA refused shipment AEK-8613440-7/31/1 from ASTRA ZENECA (United Kingdom) on Jan 19, 2021. The refused product falls under Drugs and Biologics — DAPAGLIFLOZIN (ANTI-DIABETIC). Cited charge: 75 This firm has 5 or more other import refusals on record.
Refusal details
- Date
- Jan 19, 2021
- Country
- United Kingdom
- Product Category
- Drugs and Biologics
- Product Code
- 61PCY70 DAPAGLIFLOZIN (ANTI-DIABETIC)
- Charges
- 75